🇧🇷Brazil

Multas e Sanções por Não Conformidade em Rotulagem de Alimentos

4 verified sources

Definition

Seafood manufacturers in Brasil must comply with mandatory allergen labeling (crustáceos, moluscos, peixe) and frontal warning symbols by specific deadlines: Oct 9, 2022 (new products), Oct 9, 2023 (large manufacturers), Oct 9, 2024 (microenterprises), and Oct 9, 2025 (returnable beverage packaging)[2][3][4]. ANVISA enforces compliance via inspection and administrative penalties for non-compliant products. Non-declared allergens expose companies to liability claims and product seizures.

Key Findings

  • Financial Impact: LOGIC-based estimate: ANVISA administrative fines (typical range R$ 5,000–R$ 50,000+ per violation for food products); Product recalls and market withdrawal; Liability exposure from allergen-related customer harm (estimated 3-10% of affected SKUs in non-compliant batches). Exact amounts unavailable in search results.
  • Frequency: Ongoing from Oct 9, 2022 onwards; intensified enforcement expected post-Oct 9, 2024 (microenterprise deadline) and Oct 9, 2025 (returnable packaging deadline)[2][3][4]
  • Root Cause: Manual label validation, legacy ERP systems not integrated with ANVISA requirements, product data inconsistencies across suppliers, and missed compliance deadline transitions by company size segment

Why This Matters

The Pitch: Brazilian seafood manufacturers waste time and face regulatory risk managing allergen declarations across multiple SKUs and compliance deadlines. Automation of allergen labeling workflows and inventory validation eliminates shelf-blocking non-compliance penalties and recall costs.

Affected Stakeholders

Quality Assurance Manager, Regulatory Affairs, Supply Chain / Procurement, Production Scheduling, Marketing (label design)

Deep Analysis (Premium)

Financial Impact

Financial data and detailed analysis available with full access. Unlock to see exact figures, evidence sources, and actionable insights.

Unlock to reveal

Current Workarounds

Financial data and detailed analysis available with full access. Unlock to see exact figures, evidence sources, and actionable insights.

Unlock to reveal

Get Solutions for This Problem

Full report with actionable solutions

$99$39
  • Solutions for this specific pain
  • Solutions for all 15 industry pains
  • Where to find first clients
  • Pricing & launch costs
Get Solutions Report

Methodology & Sources

Data collected via OSINT from regulatory filings, industry audits, and verified case studies.

Evidence Sources:

Related Business Risks

Request Deep Analysis

🇧🇷 Be first to access this market's intelligence